CRANBURY, NJ — PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named The Lynx Group’s toolkit, Patient Navigation in Cancer Care 2.0: Guiding patients to quality outcomes, as a Trailblazer Initiative finalist for Healthcare Provider (HCP) Education.
The toolkit contains Pfizer Oncology content examining the history and evolution of navigation, core competencies, current models of navigation, and the role of the navigator along the cancer care continuum. It also explores the importance of administrative engagement and outlines standardized metrics for the development of a successful, measurable navigation program. The toolkit was developed as a resource for professional and program development for institutions committed to making a difference in the lives of patients and in shaping the future of value-based cancer care through navigation.
“It’s an honor to be selected as a 2019 Trailblazer finalist by PM360 for this initiative,” says Brian Tyburski, President & CEO, The Lynx Group™. “The Patient Navigation in Cancer Care 2.0 toolkit was the result of close collaboration with the client and dedication of our talented team. It has been well received thus far, and our client has engaged us to develop additional toolkits to address metastatic breast and prostate cancer. We are confident that this resource will be valuable for all navigators to use and share with their administrators and oncology team to make a difference in the lives of their patients and shape the future of value-based cancer care.”
Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Winning initiatives were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on their ability to overcome challenges; the skill, innovation, and quality of planning and execution; and the effectiveness of the work. A total of 84 finalists were chosen in the 17 Initiative categories.
“Each of the 84 finalists survived a daunting evaluation process by our judges to emerge as the best among an exceptional crop of submissions,” says Anna Stashower, CEO and Publisher of PM360. “Ultimately, their innovative strategies and impressive results are industry breakthroughs—and they provide exciting examples of the type of boundary-pushing work our industry is doing as it embraces change.”
Finalists are acknowledged and winners will be honored during a special black-tie reception at Gotham Hall in New York City on Thursday, September 19, 2019. Each year, the Trailblazer Awards Gala attracts more attendees from the pharmaceutical industry than any other industry event. Profiles of all of the night’s winners will appear in PM360’s October issue.
You can also follow the awards real-time on Twitter at www.twitter.com/pm360online.
About Amplity Health
Amplity Health proudly serves as co-founder and association management company of the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Association for Value-Based Cancer Care (AVBCC).
The true partner of global healthcare companies, Amplity Health continually challenges the boundaries of medical and commercial strategies to accelerate the approval and launch of new drugs to improve the lives of patients. We are proud of our inclusive culture and our EPIIC values. Amplity has the expertise, global infrastructure, and data-driven insights to help clients overcome their medical and commercial challenges.
Amplity’s wide-ranging capabilities include clinical and medical outsourced teams; clinical and medical capability development; companion diagnostic and precision medicine solutions; medical communications; expert engagement; remote and field solutions for patients, payers, and physicians; and strategic and access consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient–provider interactions and provider treatment rationale not found through any other provider.
Amplity Health is a portfolio company of Altamont Capital Partners.
About the Academy of Oncology Nurse & Patient Navigators® (www.aonnonline.org)
The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has more than 8,200 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process.
The Journal of Oncology Navigation & Survivorship®(www.jons-online.com) is the official publication of AONN+. It is published 12 times a year and features topics related to patient navigation and survivorship care. JONS offers original research, best practices, interviews, case reports and study highlights as well as a platform through which navigators can share research and views on navigation and survivorship issues.
CONQUER: The Patient Voice Magazine™ (www.conquer-magazine.com) is the Academy of Oncology Nurse & Patient Navigators’ (AONN+) premier forum for patients with cancer. CONQUER features articles written by and for patients with cancer, survivors, nurse navigators, and other oncology team members. This magazine addresses the issues that patients, their family members, and caregivers face every day in an easy-to-read format. Issues include interviews with patients with cancer, information on access to care, and articles on lifestyle topics such as nutrition, stress management, personal finance, and legal and employer issues. CONQUER also features patient stories that are nominated for the AONN+ HERO OF HOPE™ award, which will be presented at the AONN+ Annual Conference. All stories are compiled in a special issue of CONQUER at the end of the year.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the
latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.